Zerrin Bicik

509 total citations
21 papers, 289 citations indexed

About

Zerrin Bicik is a scholar working on Nephrology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zerrin Bicik has authored 21 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 4 papers in Physiology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zerrin Bicik's work include Dialysis and Renal Disease Management (5 papers), Lysosomal Storage Disorders Research (3 papers) and Pregnancy and preeclampsia studies (2 papers). Zerrin Bicik is often cited by papers focused on Dialysis and Renal Disease Management (5 papers), Lysosomal Storage Disorders Research (3 papers) and Pregnancy and preeclampsia studies (2 papers). Zerrin Bicik collaborates with scholars based in Türkiye and Antigua and Barbuda. Zerrin Bicik's co-authors include Zeki Soypaçacı, Özlem Yavuz, D. Ozdemir, İdris Şahi̇n, İrfan Şencan, Şükrü Sindel, Hakan Özdemır, Galip Güz, Yasemin Erten and Musa Bali and has published in prestigious journals such as Fertility and Sterility, Clinica Chimica Acta and The American Journal of the Medical Sciences.

In The Last Decade

Zerrin Bicik

20 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zerrin Bicik Türkiye 11 68 59 52 42 38 21 289
Cristina Căpușă Romania 12 124 1.8× 199 3.4× 53 1.0× 66 1.6× 64 1.7× 37 487
J. G. Mongeau Canada 9 36 0.5× 68 1.2× 35 0.7× 21 0.5× 20 0.5× 20 334
Hakkı Arikan Türkiye 12 22 0.3× 153 2.6× 50 1.0× 17 0.4× 28 0.7× 59 410
Rufu Jia China 12 29 0.4× 44 0.7× 25 0.5× 20 0.5× 37 1.0× 23 316
Andrew Ma United States 11 92 1.4× 95 1.6× 29 0.6× 48 1.1× 69 1.8× 28 405
Sami Uzun Türkiye 10 32 0.5× 75 1.3× 48 0.9× 18 0.4× 39 1.0× 44 328
G.M.T. de Jong Netherlands 7 84 1.2× 51 0.9× 44 0.8× 47 1.1× 12 0.3× 8 295
Barbara Bucher Switzerland 7 22 0.3× 63 1.1× 32 0.6× 7 0.2× 9 0.2× 17 371
Enes Murat Atasoyu Türkiye 10 13 0.2× 62 1.1× 39 0.8× 5 0.1× 13 0.3× 26 340
Luigi Pavanello Italy 8 70 1.0× 151 2.6× 213 4.1× 24 0.6× 20 0.5× 13 673

Countries citing papers authored by Zerrin Bicik

Since Specialization
Citations

This map shows the geographic impact of Zerrin Bicik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zerrin Bicik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zerrin Bicik more than expected).

Fields of papers citing papers by Zerrin Bicik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zerrin Bicik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zerrin Bicik. The network helps show where Zerrin Bicik may publish in the future.

Co-authorship network of co-authors of Zerrin Bicik

This figure shows the co-authorship network connecting the top 25 collaborators of Zerrin Bicik. A scholar is included among the top collaborators of Zerrin Bicik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zerrin Bicik. Zerrin Bicik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ezgü, Fatih Süheyl, Erkan Alpsoy, Zerrin Bicik, et al.. (2022). Expert opinion on the recognition, diagnosis and management of children and adults with Fabry disease: a multidisciplinary Turkey perspective. Orphanet Journal of Rare Diseases. 17(1). 90–90. 15 indexed citations
2.
Bicik, Zerrin, et al.. (2019). Multidisciplinary approach to Fabry disease: from the eye of a neurologist. Acta Neurologica Belgica. 120(6). 1333–1339. 3 indexed citations
3.
Bindayı, Ahmet, et al.. (2017). A randomized study to assess the efficacy of herbal product to prevent cisplatin-induced nephrotoxicity in a rat model. Archivio Italiano di Urologia e Andrologia. 89(3). 192–192. 2 indexed citations
4.
Bicik, Zerrin, et al.. (2015). Safe and Successful Treatment With Agalsidase Beta During Pregnancy in Fabry Disease.. PubMed. 9(5). 406–8. 11 indexed citations
5.
Bicik, Zerrin, et al.. (2014). Association Between Serum Pregnancy-Associated Plasma Protein-A and Bicarbonate in Hemodialysis Patients. Journal of Clinical Laboratory Analysis. 28(2). 114–117. 1 indexed citations
6.
Bicik, Zerrin, et al.. (2012). Hastalarin Perspektifinden: Periton Diyalizinin Yaşama ve Ruhsal Belirtilere Etkisi. 2(4). 169–174. 1 indexed citations
7.
Bicik, Zerrin, et al.. (2012). The perspective from the patients: The effects of peritoneal dialysis on life and mental symptoms. 2(4). 169–169. 3 indexed citations
8.
Coşkun, Abdurrahman, Zerrin Bicik, Rahim Horuz, et al.. (2012). Evaluating ESWL-induced renal injury based on urinary TNF-α, IL-1α, and IL-6 levels. Urological Research. 40(5). 569–573. 12 indexed citations
9.
Dabak, Reşat, et al.. (2011). Approach to mushroom intoxication and treatment: Can we decrease mortality?. Clinics and Research in Hepatology and Gastroenterology. 36(2). 139–145. 25 indexed citations
10.
Coşkun, Abdurrahman, Zerrin Bicik, Aytekin Alçelik, et al.. (2007). Pregnancy-associated plasma protein A in dialysis patients. Clinical Chemistry and Laboratory Medicine (CCLM). 45(1). 63–6. 25 indexed citations
11.
Gülcan, Erim, Enver Erbilen, Figen Taşer, et al.. (2007). The Predictive Value of CRP Levels on Future Severe Renal Disease in Overweight and Obese Subjects Without Diabetes Mellitus and Hypertension. The American Journal of the Medical Sciences. 334(6). 444–451. 3 indexed citations
12.
Ozdemir, D., Zeki Soypaçacı, İdris Şahi̇n, Zerrin Bicik, & İrfan Şencan. (2006). <i>Ochrobactrum anthropi</i> Endocarditis and Septic Shock in a Patient with No Prosthetic Valve or Rheumatic Heart Disease: Case Report and Review of the Literature. Japanese Journal of Infectious Diseases. 59(4). 264–265. 23 indexed citations
13.
Ozdemir, D., Zeki Soypaçacı, İdris Şahi̇n, Zerrin Bicik, & İrfan Şencan. (2006). Ochrobactrum anthropi endocarditis and septic shock in a patient with no prosthetic valve or rheumatic heart disease: case report and review of the literature.. PubMed. 59(4). 264–5. 32 indexed citations
14.
15.
Bicik, Zerrin, Talat Bahçebaşı, Sevsen Kulaksızoğlu, & Özlem Yavuz. (2005). The efficacy of cystatin C assay in the prediction of glomerular filtration rate. Is it a more reliable marker for renal failure?. Clinical Chemistry and Laboratory Medicine (CCLM). 43(8). 855–61. 22 indexed citations
16.
17.
Bicik, Zerrin, et al.. (2005). Safe liver biopsy in a patient with chronic hepatitis C under continuous ambulatory peritoneal dialysis treatment.. PubMed. 24(2). 87–8. 1 indexed citations
18.
Güz, Galip, Hakan Özdemır, Yasemin Erten, et al.. (2005). <b>Intravenous Iron Therapy as a Possible Risk Factor for Atherosclerosis in End-stage Renal Disease</b>. International Heart Journal. 46(2). 255–264. 62 indexed citations
19.
Arınsoy, Turgay, Ülver Derici, Zerrin Bicik, et al.. (2004). Angiotensinogen and plasminogen activator inhibitor‐1 gene polymorphism in relation to chronic allograft dysfunction*. Clinical Transplantation. 19(1). 10–14. 14 indexed citations
20.
Yavuz, Özlem, et al.. (2004). The effect of different dialysis membranes on oxidative stress and selenium status. Clinica Chimica Acta. 346(2). 153–160. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Căpușă Breakdown of academic impact, for papers by J. G. Mongeau Breakdown of academic impact, for papers by Hakkı Arikan Breakdown of academic impact, for papers by Rufu Jia Breakdown of academic impact, for papers by Andrew Ma Breakdown of academic impact, for papers by Sami Uzun Breakdown of academic impact, for papers by G.M.T. de Jong Breakdown of academic impact, for papers by Barbara Bucher Breakdown of academic impact, for papers by Enes Murat Atasoyu Breakdown of academic impact, for papers by Luigi Pavanello
Rankless by CCL
2026